All sites C00-96,D32-33,D42-43,D45-47,D76 514 88.1 2.7 3.7 1.3 4.2
Mouth, pharynx C00-14 7 86.5 2.7 - - 10.8
  Lip C00 1 100.0 - - - -
  Tongue C02 1 100.0 - - - -
  Mouth, other C03-06 3 78.6 - - - 21.4
  Salivary glands C07-08 1 66.7 16.7 - - 16.7
  Pharynx C01,C09-14 1 100.0 - - - -
Digestive organs C15-26 99 80.5 2.0 9.3 2.0 6.2
  Oesophagus C15 3 86.7 - 6.7 6.7 -
  Stomach C16 12 93.2 - 3.4 - 3.4
  Small intestine C17 1 100.0 - - - -
  Colon C18 33 95.2 - 1.8 - 3.0
  Rectum, rectosigmoid C19-20 16 96.2 - - 1.3 2.6
  Anus C21 1 100.0 - - - -
  Liver C22 7 79.4 2.9 8.8 2.9 5.9
  Gallbladder, bile ducts C23-24 9 67.4 4.7 14.0 2.3 11.6
  Pancreas C25 17 37.6 8.2 32.9 7.1 14.1
  Other digestive organs C26 2 25.0 - 37.5 - 37.5
Respiratory organs C30-39 26 60.8 19.2 13.1 1.5 5.4
  Nose, sinuses C30-31 0 100.0 - - - -
  Larynx, epiglottis C32 0 100.0 - - - -
  Lung, trachea C33-34 25 60.3 19.8 13.5 1.6 4.8
  Mediastinum, pleura C38 - - - - - -
Bone C40-41 0 100.0 - - - -
Melanoma of the skin C43 20 100.0 - - - -
Skin, non-melanoma C44 26 100.0 - - - -
Mesothelioma C45 0 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 3 94.1 - - - 5.9
Breast C50 156 99.0 0.1 - 0.3 0.6
Female genital organs C51-58 63 93.3 2.5 0.3 0.6 3.2
  Cervix uteri C53 5 100.0 - - - -
  Corpus uteri C54 31 99.4 - - - 0.6
  Uterus, other C55,C58 0 100.0 - - - -
  Ovary C56 18 80.9 9.0 1.1 1.1 7.9
  Other female genital C51-52,C57 8 92.7 - - 2.4 4.9
Urinary organs C64-68 21 84.1 1.9 4.7 1.9 7.5
  Kidney C64 15 79.7 1.4 5.4 2.7 10.8
  Bladder and urinary tract2 C65-68 7 93.9 3.0 3.0 - -
Eye C69 0 50.0 - - 50.0 -
Brain, central nervous system C70-72,D32-33,D42-43 17 81.9 - 8.4 2.4 7.2
Thyroid gland C73 12 98.3 1.7 - - -
Other endocrine glands C74-75 0 100.0 - - - -
Illdefined or unknown C76,C80 15 56.6 10.5 19.7 3.9 9.2
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 47 75.7 6.0 1.7 4.3 12.3
  Hodgkin lymphoma C81 1 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 21 97.1 1.0 - - 1.9
  Malignant immunoproliferative diseases C88 0 50.0 - - 50.0 -
  Myeloma and other plasma cell tumors C90 6 55.2 3.4 6.9 13.8 20.7
  Leukaemia C91-95 12 63.9 11.5 1.6 3.3 19.7
  Myelodysplastic syndromes D46 2 18.2 27.3 9.1 9.1 36.4
  Myeloproliferaitive neoplasms D45,D47 4 59.1 9.1 - 9.1 22.7
Not included above
  Carcinoma in situ of the breast D05 10 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 47 100.0 - - - -
  Borderline tumour of the ovary D39 5 91.3 - - - 8.7
  Basal cell carcinoma of the skin 162 99.9 - - 0.1 -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.